Zobrazeno 1 - 10
of 12
pro vyhledávání: '"Iñigo González-Mazón"'
Autor:
Vanesa Calvo-Río, Lara Sánchez-Bilbao, Carmen Álvarez-Reguera, Santos Castañeda, Iñigo González-Mazón, Rosalía Demetrio-Pablo, Miguel A. González-Gay, Ricardo Blanco
Publikováno v:
Therapeutic Advances in Musculoskeletal Disease, Vol 14 (2022)
Ocular disease, such as scleritis and peripheral ulcerative keratitis (PUK), may be a serious ocular complication. We present a patient with severe and refractory PUK treated with baricitinib. A review of the literature on Janus kinase inhibitors (JA
Externí odkaz:
https://doaj.org/article/9d2845bba80a4693a4e3cd9e0f1f2cf7
Autor:
Raúl Fernández-Ramón, Jorge J. Gaitán-Valdizán, Iñigo González-Mazón, Lara Sánchez-Bilbao, José L. Martín-Varillas, David Martínez-López, Rosalía Demetrio-Pablo, M.Carmen González-Vela, Iván Ferraz-Amaro, Santos Castañeda, Miguel A. González-Gay, Ricardo Blanco
Publikováno v:
European Journal of Internal Medicine. 108:60-67
The aim of this study was to evaluate the frequency of systemic treatment in a cohort of sarcoidosis patients and identify presenting clinical features as predictive factors of the need for systemic immunosuppressive therapy.Retrospective study of 34
Autor:
Javier Rueda-Gotor, Iván Ferraz-Amaro, Fernanda Genre, Iñigo González Mazón, Alfonso Corrales, Virginia Portilla, Javier Llorca, Mario Agudo-Bilbao, Elena Aurrecoechea, Rosa Expósito, Vanesa Hernández-Hernández, Juan Carlos Quevedo-Abeledo, Carlos Rodríguez-Lozano, Clementina Lopez-Medina, María Lourdes Ladehesa-Pineda, Santos Castañeda, Esther F. Vicente, Cristina Fernández-Carballido, M Paz Martínez-Vidal, David Castro-Corredor, Joaquín Anino-Fernández, Diana Peiteado, Chamaida Plasencia-Rodríguez, María Luz García Vivar, Eva Galíndez-Agirregoikoa, Esther Montes Perez, Carlos Fernández Díaz, Ricardo Blanco, Miguel Ángel González-Gay
Publikováno v:
Seminars in Arthritis and Rheumatism. 57:152096
To determine the potential impact of extra-articular manifestations (EAMs) on disease characteristics and cardiovascular (CV) risk in patients with axial spondylarthritis (axSpA).This is a cross-sectional study from the AtheSpAin cohort, a Spanish mu
Autor:
Javier Rueda-Gotor, Iván Ferraz-Amaro, Fernanda Genre, Iñigo González-Mazón, Alfonso Corrales, Vanesa Calvo-Rio, Virginia Portilla, Javier Llorca, Rosa Expósito, Vanesa Hernández-Hernández, Juan Carlos Quevedo-Abeledo, Carlos Rodríguez-Lozano, Clementina Lopez-Medina, María Lourdes Ladehesa-Pineda, Santos Castañeda, Esther F. Vicente, Cristina Fernández-Carballido, M Paz Martínez-Vidal, David Castro-Corredor, Joaquín Anino-Fernández, Diana Peiteado, Chamaida Plasencia-Rodríguez, María Luz García-Vivar, Eva Galíndez-Agirregoikoa, Esther Montes-Perez, Carlos Fernández-Díaz, Ricardo Blanco, Miguel Ángel González-Gay
Publikováno v:
Semin Arthritis Rheum . 2022 May 28;55:152037
UCrea Repositorio Abierto de la Universidad de Cantabria
Universidad de Cantabria (UC)
UCrea Repositorio Abierto de la Universidad de Cantabria
Universidad de Cantabria (UC)
Objectives: To identify disease-related factors associated with subclinical atherosclerosis and cardiovascular (CV) events in a large series of patients with axial spondyloarthritis (axSpA) and to identify possible differences in the effect of the po
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ad132af0f0d0e6c82d160818e2aaafa3
http://hdl.handle.net/10902/25090
http://hdl.handle.net/10902/25090
Autor:
Nuria Vegas-Revenga, José Luis Martín-Varillas, Vanesa Calvo-Río, Iñigo González-Mazón, Lara Sánchez-Bilbao, Emma Beltrán, Alejandro Fonollosa, Olga Maíz, Ana Blanco, Miguel Cordero-Coma, Norberto Ortego, Ignacio Torre, Félix Francisco Hernández, Santiago Muñoz-Fernández, María Mar Esteban Ortega, Manuel Diaz-Llopis, Joaquin Cañal, Juan Antonio Ventosa, Rosalía Demetrio-Pablo, Mario Agudo-Bilbao, Lucia Domínguez-Casas, José Luis Hernández, Santos Castañeda, Miguel A. González-Gay, Ricardo Blanco
Publikováno v:
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY
r-IIS La Fe. Repositorio Institucional de Producción Científica del Instituto de Investigación Sanitaria La Fe
instname
Scopus-Elsevier
r-IIS La Fe. Repositorio Institucional de Producción Científica del Instituto de Investigación Sanitaria La Fe
instname
Scopus-Elsevier
Objective Rapid control of intraocular inflammation in non-infectious uveitis (NIU) is mandatory to avoid irreversible structural and functional damage. In this study, we assessed the efficacy and safety of intravenous methylprednisolone (IVMP) pulse
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::80637a80e76bc4dcf2d2071de85ec67c
https://fundanet.iislafe.san.gva.es/publicaciones/ProdCientif/PublicacionFrw.aspx?id=13833
https://fundanet.iislafe.san.gva.es/publicaciones/ProdCientif/PublicacionFrw.aspx?id=13833
Autor:
Carlos Fernández Díaz, Esther F. Vicente, Javier Rueda-Gotor, María Luz García Vivar, Juan Carlos Quevedo-Abeledo, Esther Montes Perez, Carlos Rodríguez-Lozano, Ricardo Blanco, Rafaela Ortega-Castro, María Lourdes Ladehesa-Pineda, Santos Castañeda, Rosa Expósito, Cristina Fernández-Carballido, Joaquín Anino-Fernández, Alfonso Corrales, M Paz Martínez-Vidal, Eva Galíndez-Agirregoikoa, Iñigo González Mazón, Chamaida Plasencia-Rodríguez, Diana Peiteado, Fernanda Genre, Javier Llorca, Miguel A. González-Gay, David Castro-Corredor, Virginia Portilla, Iván Ferraz-Amaro
Publikováno v:
Ther Adv Musculoskelet Dis . 2021 Jul 28;13:1759720X211033755
Therapeutic Advances in Musculoskeletal Disease
THERAPEUTIC ADVANCES IN MUSCULOSKELETAL DISEASE
r-ISABIAL. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica y Sanitaria de Alicante
instname
r-FISABIO. Repositorio Institucional de Producción Científica
UCrea Repositorio Abierto de la Universidad de Cantabria
Universidad de Cantabria (UC)
Therapeutic Advances in Musculoskeletal Disease, Vol 13 (2021)
Therapeutic Advances in Musculoskeletal Disease
THERAPEUTIC ADVANCES IN MUSCULOSKELETAL DISEASE
r-ISABIAL. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica y Sanitaria de Alicante
instname
r-FISABIO. Repositorio Institucional de Producción Científica
UCrea Repositorio Abierto de la Universidad de Cantabria
Universidad de Cantabria (UC)
Therapeutic Advances in Musculoskeletal Disease, Vol 13 (2021)
Background: Axial spondyloarthritis (axSpA) patients are known to have a higher prevalence of several comorbidities, including, among others, an increased risk of atherosclerosis, hypertension, dyslipidemia, and diabetes. The purpose of the present s
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4b48b61bee594fc9605bf59595d94dae
http://hdl.handle.net/10902/24044
http://hdl.handle.net/10902/24044
Autor:
David Martínez-López, Lara Sánchez-Bilbao, Marina De Cos-Gómez, Iñigo González-Mazón, Emilio Rodrigo-Calabia, Juan Carlos Ruiz-San Millán, Javier Gómez Román, Santos Castañeda, Miguel Angel González-Gay, Jose Luis Hernández, Ricardo Blanco
Publikováno v:
Clinical and experimental rheumatology. 40(3)
Lupus nephritis (LN) is a severe complication of systemic lupus erythematosus (SLE). Unfortunately, 10-20% of patients with LN develop end-stage renal disease (ESRD), and renal transplantation may be a therapeutic option. However, concerns about LN r
Autor:
Sara Remuzgo-Martínez, Javier Rueda-Gotor, Verónica Pulito-Cueto, Raquel López-Mejías, Alfonso Corrales, Leticia Lera-Gómez, Raquel Pérez-Fernández, Virginia Portilla, Íñigo González-Mazón, Ricardo Blanco, Rosa Expósito, Cristina Mata, Javier Llorca, Vanesa Hernández-Hernández, Carlos Rodríguez-Lozano, Nuria Barbarroja, Rafaela Ortega-Castro, Esther Vicente, Cristina Fernández-Carballido, María Paz Martínez-Vidal, David Castro-Corredor, Joaquín Anino-Fernández, Diana Peiteado, Chamaida Plasencia-Rodríguez, Eva Galíndez-Agirregoikoa, María Luz García-Vivar, Nuria Vegas-Revenga, Irati Urionaguena, Oreste Gualillo, Juan Carlos Quevedo-Abeledo, Santos Castañeda, Iván Ferraz-Amaro, Miguel Á. González-Gay, Fernanda Genre
Publikováno v:
Frontiers in Immunology, Vol 13 (2022)
IntroductionPatients with axial spondyloarthritis (axSpA) have a high disease burden mainly due to the rheumatic disease itself, and also exhibit accelerated atherosclerosis, that leads to a higher incidence of cardiovascular (CV) disease. Accordingl
Externí odkaz:
https://doaj.org/article/cc1ef92916f346c3b103e7e262fc2fb1
Autor:
Javier Rueda-Gotor, Raquel López-Mejías, Sara Remuzgo-Martínez, Verónica Pulito-Cueto, Alfonso Corrales, Leticia Lera-Gómez, Virginia Portilla, Íñigo González-Mazón, Ricardo Blanco, Rosa Expósito, Cristina Mata, Javier Llorca, Vanesa Hernández-Hernández, Carlos Rodríguez-Lozano, Nuria Barbarroja, Rafaela Ortega Castro, Esther Vicente, Cristina Fernández-Carballido, María Paz Martínez-Vidal, David Castro-Corredor, Joaquín Anino-Fernández, Diana Peiteado, Chamaida Plasencia-Rodríguez, Eva Galíndez-Agirregoikoa, María Luz García-Vivar, Oreste Gualillo, Juan Carlos Quevedo-Abeledo, Santos Castañeda, Iván Ferraz-Amaro, Miguel Á. González-Gay, Fernanda Genre
Publikováno v:
Arthritis Research & Therapy, Vol 23, Iss 1, Pp 1-9 (2021)
Abstract Background Vaspin is a novel anti-inflammatory adipokine associated with cardiovascular (CV) disease and inflammation in chronic inflammatory conditions different from axial spondyloarthritis (axSpA). Given the high incidence of CV disease (
Externí odkaz:
https://doaj.org/article/37eebbcda0594b05aafabd6baf922061
Autor:
Lara Sánchez-Bilbao, David Martínez-López, Marcelino Revenga, Ángel López-Vázquez, Elia Valls-Pascual, Belén Atienza-Mateo, Beatriz Valls-Espinosa, Olga Maiz-Alonso, Ana Blanco, Ignacio Torre-Salaberri, Verónica Rodríguez-Méndez, Ángel García-Aparicio, Raúl Veroz-González, Vega Jovaní, Diana Peiteado, Margarita Sánchez-Orgaz, Eva Tomero, Francisco J. Toyos-Sáenz de Miera, Valvanera Pinillos, Elena Aurrecoechea, Ángel Mora, Arantxa Conesa, Manuel Fernández-Prada, Juan A. Troyano, Vanesa Calvo-Río, Rosalía Demetrio-Pablo, Íñigo González-Mazón, José L. Hernández, Santos Castañeda, Miguel Á. González-Gay, Ricardo Blanco
Publikováno v:
Journal of Clinical Medicine, Vol 9, Iss 9, p 2816 (2020)
Graves’ orbitopathy (GO) is the most common extrathyroidal manifestation of Graves’ disease (GD). Our aim was to assess the efficacy and safety of Tocilizumab (TCZ) in GO refractory to conventional therapy. This was an open-label multicenter stud
Externí odkaz:
https://doaj.org/article/d41e69654d374741be2dedd18e1dd030